TY - JOUR
T1 - What Does it Take to Make Model-Informed Precision Dosing Common Practice?
T2 - Report from the 1st Asian Symposium on Precision Dosing
AU - Polasek, Thomas M.
AU - Rostami-Hodjegan, Amin
AU - Yim, Dong Seok
AU - Jamei, Masoud
AU - Lee, Howard
AU - Kimko, Holly
AU - Kim, Jae Kyoung
AU - Nguyen, Phuong Thi Thu
AU - Darwich, Adam S.
AU - Shin, Jae Gook
PY - 2019/3
Y1 - 2019/3
N2 - Model-informed precision dosing (MIPD) is modeling and simulation in healthcare to predict the drug dose for a given patient based on their individual characteristics that is most likely to improve efficacy and/or lower toxicity in comparison to traditional dosing. This paper describes the background and status of MIPD and the activities at the 1st Asian Symposium of Precision Dosing. The theme of the meeting was the question, “What does it take to make MIPD common practice?” Formal presentations highlighted the distinction between genetic and non-genetic sources of variability in drug exposure and response, the use of modeling and simulation as decision support tools, and the facilitators to MIPD implementation. A panel discussion addressed the types of models used for MIPD, how the pharmaceutical industry views MIPD, ways to upscale MIPD beyond academic hospital centers, and the essential role of healthcare professional education as a way to progress. The meeting concluded with an ongoing commitment to use MIPD to improve patient care.
AB - Model-informed precision dosing (MIPD) is modeling and simulation in healthcare to predict the drug dose for a given patient based on their individual characteristics that is most likely to improve efficacy and/or lower toxicity in comparison to traditional dosing. This paper describes the background and status of MIPD and the activities at the 1st Asian Symposium of Precision Dosing. The theme of the meeting was the question, “What does it take to make MIPD common practice?” Formal presentations highlighted the distinction between genetic and non-genetic sources of variability in drug exposure and response, the use of modeling and simulation as decision support tools, and the facilitators to MIPD implementation. A panel discussion addressed the types of models used for MIPD, how the pharmaceutical industry views MIPD, ways to upscale MIPD beyond academic hospital centers, and the essential role of healthcare professional education as a way to progress. The meeting concluded with an ongoing commitment to use MIPD to improve patient care.
KW - MIPD
KW - modeling and simulation
UR - http://www.scopus.com/inward/record.url?scp=85059798122&partnerID=8YFLogxK
U2 - 10.1208/s12248-018-0286-6
DO - 10.1208/s12248-018-0286-6
M3 - Article
C2 - 30627939
AN - SCOPUS:85059798122
SN - 1550-7416
VL - 21
JO - AAPS Journal
JF - AAPS Journal
IS - 2
M1 - 17
ER -